Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

0
Player Avatar euphorbus (46.33) Submitted: 6/3/2009 10:20:16 PM : Outperform Start Price: $25.26 ONXX Score: +43.27

Onyx will get bought out within two years.

Featured Broker Partners


Advertisement